BioCentury
ARTICLE | Financial News

IPO roundup: Avrobio, Aptinyx, Magenta, Kezar, Xeris

June 22, 2018 7:15 PM UTC

Five biopharmas priced IPOs late on June 20, raising a total of more than $460 million. Four of the five upsized their offerings to sell more shares than anticipated; one of those, Avrobio, also priced above its proposed range.

Avrobio raised $99.7 million through the sale of 5.2 million shares at $19. The price valued Avrobio at $439.8 million. The company had planned to sell 4.4 million shares at $16-$18. Underwriters are Morgan Stanley, Cowen, Wells Fargo and Wedbush PacGrow...